AAC
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
AAC.00945-07v1
52/2/757    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Holmes, R. L.
Right arrow Articles by Jorgensen, J. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Holmes, R. L.
Right arrow Articles by Jorgensen, J. H.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, February 2008, p. 757-760, Vol. 52, No. 2
0066-4804/08/$08.00+0     doi:10.1128/AAC.00945-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Inhibitory Activities of 11 Antimicrobial Agents and Bactericidal Activities of Vancomycin and Daptomycin against Invasive Methicillin-Resistant Staphylococcus aureus Isolates Obtained from 1999 through 2006{triangledown}

Robert L. Holmes1* and James H. Jorgensen2

Infectious Disease Service, Brooke Army Medical Center, Fort San Houston, Texas 78234,1 Department of Pathology, University of Texas Health Science Center and University Hospital, San Antonio, Texas 782012

Received 22 July 2007/ Returned for modification 3 September 2007/ Accepted 6 November 2007

We assessed MICs and minimal bactericidal concentrations of vancomycin, daptomycin, and nine other antimicrobials against methicillin-resistant Staphylococcus aureus isolates obtained from 1999 through 2006. No vancomycin, daptomycin, or linezolid resistance was observed. Clindamycin, gentamicin, and ciprofloxacin resistance decreased significantly. No tolerance to vancomycin or daptomycin was observed, nor was MIC creep seen.

* Corresponding author. Present address: 301 Fisher St., Keesler AFB, MS 39534. Phone: (228) 376-3568. Fax: (228) 376-0145. E-mail: robert.holmes{at}keesler.af.mil

{triangledown} Published ahead of print on 26 November 2007.

Antimicrobial Agents and Chemotherapy, February 2008, p. 757-760, Vol. 52, No. 2
0066-4804/08/$08.00+0     doi:10.1128/AAC.00945-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:



Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Clin. Vaccine Immunol. Clin. Microbiol. Rev.
J. Clin. Microbiol. ALL ASM JOURNALS

Copyright © 2008 by the American Society for Microbiology. All rights reserved.